Thyrocare Technologies Ltd (IN:THYROCARE)
:THYROCARE
Want to see IN:THYROCARE full AI Analyst Report?
THYROCARE Stock Chart & Stats
₹459.10
-₹16.20(-1.70%)
At close: 4:00 PM EST
₹459.10
-₹16.20(-1.70%)
Day’s Range― - ―
52-Week Range₹292.42 - ₹537.97
Previous CloseN/A
Volume114.81K
Average Volume (3M)56.30K
Market Cap
₹75.51B
Enterprise Value₹24.71B
Total Cash (Recent Filing)₹1.92B
Total Debt (Recent Filing)₹246.80M
Price to Earnings (P/E)34.0
Beta0.60
Next Earnings
Aug 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.68%
Share Statistics
EPS (TTM)24.16
Shares Outstanding159,165,310
10 Day Avg. Volume44,587
30 Day Avg. Volume56,302
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)9.48
Price to Sales (P/S)6.69
P/FCF Ratio28.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.9
Revenue Forecast (FY)₹9.67B
Bulls Say, Bears Say
Bulls Say
Low LeverageA very low debt-to-equity (~0.09) gives durable financial flexibility, lowering refinancing and solvency risk. This conservatism supports continued capex for automation, resilience through cyclical downturns, and optionality for acquisitions or shareholder returns without stressing liquidity.
Strong Cash GenerationConsistent operating cash flow and FCF close to net income indicate high cash conversion, underpinning sustainable reinvestment in labs and the collection network. Strong cash generation supports funding organic growth, potential dividends, and buffers against episodic expense shocks.
Improving Returns & GrowthMaterial ROE improvement and renewed revenue acceleration reflect better capital efficiency and commercial traction in preventive diagnostics. Higher returns imply effective capital deployment in automated labs and collection channels, supporting durable profitability if execution continues.
Bears Say
Margin VolatilitySharp swings in gross and net margins across years create uncertainty about sustainable profitability. For a high-volume diagnostics model, volatile margins weaken predictability of cash flows, complicate capacity planning and pricing strategy, and raise the execution bar for management.
Uneven Free Cash Flow GrowthAlthough recent FCF surged, historical unevenness signals that cash generation can be episodic. Irregular FCF complicates multi-year investment plans, dividend consistency, and debt repayment pacing, reducing the reliability of cash-backed strategic initiatives.
Rising Balance-Sheet UsageA recent uptick in leverage, while still low, narrows the conservative cushion. In the presence of margin swings and capex needs for automation or network expansion, increased debt usage could raise financial risk and limit flexibility if revenue or margins weaken.
Thyrocare Technologies Ltd News
THYROCARE FAQ
What was Thyrocare Technologies Ltd’s price range in the past 12 months?
Thyrocare Technologies Ltd lowest stock price was ₹292.42 and its highest was ₹537.97 in the past 12 months.
What is Thyrocare Technologies Ltd’s market cap?
Thyrocare Technologies Ltd’s market cap is ₹75.51B.
When is Thyrocare Technologies Ltd’s upcoming earnings report date?
Thyrocare Technologies Ltd’s upcoming earnings report date is Aug 04, 2026 which is in 74 days.
How were Thyrocare Technologies Ltd’s earnings last quarter?
Thyrocare Technologies Ltd released its earnings results on May 07, 2026. The company reported ₹3.06 earnings per share for the quarter, missing the consensus estimate of ₹5.4 by -₹2.34.
Is Thyrocare Technologies Ltd overvalued?
According to Wall Street analysts Thyrocare Technologies Ltd’s price is currently Overvalued.
Does Thyrocare Technologies Ltd pay dividends?
Thyrocare Technologies Ltd pays a Quarterly dividend of ₹2.333 which represents an annual dividend yield of 0.68%. See more information on Thyrocare Technologies Ltd dividends here
What is Thyrocare Technologies Ltd’s EPS estimate?
Thyrocare Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Thyrocare Technologies Ltd have?
Thyrocare Technologies Ltd has 159,165,310 shares outstanding.
What happened to Thyrocare Technologies Ltd’s price movement after its last earnings report?
Thyrocare Technologies Ltd reported an EPS of ₹3.06 in its last earnings report, missing expectations of ₹5.4. Following the earnings report the stock price went up 1.737%.
Which hedge fund is a major shareholder of Thyrocare Technologies Ltd?
Currently, no hedge funds are holding shares in IN:THYROCARE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Thyrocare Technologies Ltd
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Technical Analysis
Krsnaa Diagnostics Limited
―
Medi Assist Healthcare Services Limited
―
Metropolis Healthcare Ltd.
―
Morepen Laboratories Limited
―
Vijaya Diagnostic Centre Ltd.
―